Delta-8 Trademarks Update

Home | Canna Law Blog | Delta-8 Trademarks Update The impact on Delta-8 THC ("D8") of AK Futures v. Boyd Street Distro, a 2022 Ninth Circuit decision, has been widely exaggerated. As my colleague Griffen Thorne explains: What AK Futures actually did was affirm a preliminary ruling in a trademark dispute where legality of delta-8 products was one of a number of issues at play. In order to have a protectible trademark, the good or service must be lawful in commerce. The infringer argued that delta-8 products were not lawful. As part of the preliminary injunction, the Ninth Circuit agreed that the plaintiff was “likely” to succeed in establishing that the products were lawful, if they came from hemp and if they contained under 0.3% delta-9 THC. This was a preliminary ruling, but it’s likely that the court would rule similarly on some sort of final ruling. However, to claim that this case is the be-all-end-all for delta-8 is just, well, wrong. The case is not precedential anywhere outside of the Ninth Circuit. The AK Futures court held that "AK Futures is likely to succeed on its trademark claim because its delta-8 THC products are not prohibited by federal law, and they may therefore support a valid trademark." A year and a half later, have any D8 products supported a valid trademark? According to USPTO, as of January 2, 2024, it has registered four trademarks with the term "delta-8" included in their goods and services identifications. In all four cases, the mention of D8 is exclusionary, stipulating that the goods or services described cannot be or involve goods containing delta-8. For example, one of the descriptions is "Bar soap; Body butter; Body scrub; Body sprays; Bubble bath; Lip cream; Shower gel; Skin lotions; Cosmetic bath salts; Lip balm ... all of the foregoing not containing delta-8 tetrahydrocannabinol THC ..." In this case, initially USPTO refused the application, noting in an office action that: the Applicant's website clearly states 'All spa products are made with CBD and Delta8 THC!' Thus, the identification of goods is broad enough to include goods that contain Delta-8. As discussed above and as reflected in the attached documents, tetrahydrocannabinols are listed on Schedule I under the CSA. Specifically, Schedule I identifies 'THC, Delta-8 THC, Delta-9 THC, dronabinol and others.' The office action goes on to explain that 2018 Farm Bill's carveout of hemp from the Controlled Substances Act's prohibition on marijuana "explicitly applies to delta-9 THC, and this delta-9 limitation language to the identification of goods does not convert Schedule I unlawful goods (e.g., delta-8 THC) to goods that may be lawfully used in commerce." Bear in mind that the office action was issued on July 7, 2022 - a month and a half after the AK Futures decision was handed down - yet USPTO did not equivocate and plainly referred to delta-8 goods as unlawful. There are over a hundred pending applications identifying delta-8 goods and services. Perhaps in its treatment of these, USPTO will take a different tack. So far, however, it is clear that AK Futures did not change USPTO's approach and registration of a trademark in connection to D8 products has not occurred. Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Fred Rocafort Fred leads Harris Sliwoski’s intellectual property practice and is the coordinator of the firm’s international team. Much of Fred’s practice consists of helping cannabis businesses protect their brands. He also works with entrepreneurs and companies entering the Web3 space, a new frontier for IP law. Prior to joining Harris Sliwoski, Fred worked overseas for more than a decade, in both government and private sector roles. Fred is a regular contributor to the award-winning China Law Blog and Canna Law Blog. Fred began his career overseas as a U.S. consular officer in Guangzhou, China, where he advocated for fairer treatment of American companies and citizens in China and for stronger intellectual property rights enforcement. After entering the private sector, Fred worked at a Shanghai law firm as a foreign legal advisor and later joined one of the oldest American law firms in China, helping foreign companies navigate the Chinese legal environment. He also led the legal team at a Hong Kong-based brand protection consultancy, spending most of his time out in the field, protecting clients against counterfeiters and fraudsters in Greater China, Southeast Asia and Latin America. In addition to his IP work, as a native Spanish speaker, Fred works closely with different Harris Sliwoski teams on Latin America and Spain matters. Fred also provides advice to cannabis industry participants and other businesses on import and export transactions. Fred is an ardent supporter of FC Barcelona—and would be even in the absence of Catalan forebears who immigrated to Puerto Rico in the mid-1800s. Harris Sliwoski Attorney Read more posts [email protected] Read More Intellectual Property/Branding Learn more about our Cannabis Law Practice Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply